[1]蒲双双,李金星.外泌体在疾病实验诊断和临床治疗中的研究进展[J].现代检验医学杂志,2018,33(04):160-164.[doi:10.3969/j.issn.1671-7414.2018.04.045]
 PU Shuang-shuang,LI Jin-xing.Research Progress of Exosome in the Laboratory Diagnosis and Clinic Treatment of Disease[J].Journal of Modern Laboratory Medicine,2018,33(04):160-164.[doi:10.3969/j.issn.1671-7414.2018.04.045]
点击复制

外泌体在疾病实验诊断和临床治疗中的研究进展()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年04期
页码:
160-164
栏目:
综述
出版日期:
2018-08-30

文章信息/Info

Title:
Research Progress of Exosome in the Laboratory Diagnosis and Clinic Treatment of Disease
文章编号:
1671-7414(2018)04-160-05
作者:
蒲双双李金星
山东中医药大学附属医院检验科,济南250011
Author(s):
PU Shuang-shuangLI Jin-xing
the Affiliated Hospital of Shandong Ttraditional Chinese Medicine University,Jinan 250011,China
关键词:
外泌体 实验诊断 临床治疗
分类号:
R446
DOI:
10.3969/j.issn.1671-7414.2018.04.045
文献标志码:
A
摘要:
外泌体是一种分泌囊泡,广泛分布于血液、尿液等几乎所有体液中,无创易获取,其内包含有丰富的miRNA及蛋白质成分,可敏感的反映来源细胞的生理病理状态,分析外泌体的基因芯片和蛋白质谱可以为疾病筛查和实验诊断提供依据。另外,外泌体在肿瘤治疗方面也具有很好的应用前景。它可用作基因和治疗药物运载的良好载体,靶向运送和抑制肿瘤,也可在人为上调特定分子的表达后增强机体的抗肿瘤免疫,还有被开发成肿瘤疫苗的潜质。该文就血液和尿液来源的外泌体中miRNA和蛋白质组分在人体各个系统疾病实验诊断方面的相关研究以及外泌体在疾病临床治疗尤其是肿瘤治疗中的研究进展作如下综述。
Abstract:
Abstract:The exosome is a kind of secretory vesicles,andwidely distributed in almost all body fluids such as blood and urine,so it caneasily be obtained noninvasively.The exosome which is rich in miRNA and proteins can sensitively reflect the physiological and pathological state of its source cells,the analysis of gene and protein in the exosome can provide the basis for screening and experimental diagnosis of diseases.In addition,exosomeshave a good application prospect in tumor treatment.It can be used as a good carrier of genes and drug,targeting delivery and inhibiting tumor,and it can enhance the human anti-tumor immunity after artificially raised the expression ofspecific molecular,and it can also be developed into a potential tumor vaccine.This article summarizes the research progress of mi RNA and protein in exosomes from human blood and urine in experimental diagnosis of various diseases and exosomes in clinical treatment of diseases,especially in tumor treatment.

参考文献/References:

[1] Melo SA,Luecke LB,Kahlert C,et al.Glypican-1 identifies cancer exosomes and detects early pancreatic cancer[J].Nature,2015,523(7559):177-182.
[2] Madhavan B,Yue S,Galli U,et al.Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity[J].International Journal of Cancer,2015,136(11):2616-2627.
[3] Que R,Ding G,Chen J,et al.Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma[J].WorldJournal of Surgical Oncology,2013,11(1):219.
[4] Costa-Silva B,Aiello NM,Ocean AJ,et al.Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver[J].Nature Cell Biology,2015,17(6):816-826.
[5] Sohn W,Kim J,Kang SH,et al.Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma[J].Experimental & Molecular Medicine,2015,47(9):e184.
[6] Sugimachi K,Matsumura T,Hirata H,et al.Identification of a bona fidemicroRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation[J].British Journal of Cancer,2015,112(3):532-538.
[7] He M,Qin H,Poon TCW,et al.Hepatocellular carcinoma-derived exosomespromote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs[J].Carcinogenesis,2015,36(9):1008-1018.
[8] Li Q,Shao Y,Zhang X,et al.Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer[J].Tumor Biology,2015,36(3):2007-2012.
[9] Ogata-Kawata H,Izumiya M,Kurioka D,et al.Circulating exosomal microRNAs as biomarkers of colon cancer[J].PLoS One, 2014,9(4):e92921.
[10] Matsumura T,Sugimachi K,Iinuma H,et al.Exosomal microRNA inserum is a novel biomarker of recurrence in human colorectal cancer[J].British Journal of Cancer,2015,113(2):275-281.
[11] Tauro BJ,Greening DW,Mathias RA,et al.Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids[J].Molecular & Cellular Proteomics,2013,12(3):587-598.
[12] Yoshioka Y,Kosaka N,Konishi Y,et al.Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen[J].Nature Communications,2014,5(4):3591.
[13] Cazzoli R,Buttitta F,Nicola MD,et al.MicroRNAs derived from circulating exosomes as non-invasive biomarkers for screening and diagnose lung cancer[J].Journal of Thoracic Oncology,2013,8(9):1156-1162.
[14] Munagala R,Aqil F,Gupta RC.Exosomal miRNAs as biomarkers of recurrentlung cancer[J].Tumor Biology,2016,37(8):10703-10714.
[15] Jakobsen KR,Paulsen BS,B(¨overo)kaeR,et al.Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma[J].Journal of Extracellular Vesicles,2015,4:26659.
[16] Manterola L,Guruceaga E,Pérez-Larraya JG,et al.A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool[J].Neuro Oncology,2014,16(4):520-527.
[17] Lugli G,Cohen AM,Bennett DA,et al.Plasma exosomal miRNAs in personswith and without alzheimer disease:Altered expression and prospects for biomarkers[J].PLoS One,2015,10(10):e0139233.
[18] Dong HH,Yi S,Seo H,et al.Increased DJ-1 in urine exosome of koreanmales with Parkinson's Disease[J].Biomed Research International,2014,2014(3):704678.
[19] Roccaro AM,Sacco A,Maiso P,et al.BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression[J].J Clin Invest,2013,123(4):1542-1555.
[20] Matsumoto S,Sakata Y,Suna S,et al.Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction[J].Circulation Research,2013,113(3):322-326.
[21] Chen HH,Lai PF,Lan YF,et al.Exosomal ATF3 RNA attenuates pro-inflammatory gene MCP-1 transcription in renal ischemia-reperfusion[J].Journal ofCellular Physiology,2014,229(9):1202-1211.
[22] Lü LL,Cao YH,Ni HF,et al.MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis[J].American Journal of Physiology RenalPhysiology,2013,305(8):F1220-F1227.
[23] Lü LL,Cao YH,Pan MM,et al.CD2AP mRNA in urinary exosome as biomarker of kidney disease[J].Clinica Chimica Acta,2014,428(2):26-31.
[24] Barutta F,Tricarico M,Corbelli A,et al.Urinary exosomal microRNAs inincipient diabetic nephropathy[J].PLoS One,2013,8(11):e73798.
[25] Kalani A,Mohan A,Godbole MM,et al.Wilm's tumor-1 protein levels inurinary exosomes from diabetic patients with or without proteinuria[J].PLoSOne,2013,8(3):e60177.
[26] Sole C,Cortes-Hernandez J,Felip ML,et al.miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis[J].Nephrology,Dialysis,Transplantation,2015,30(9):1488-1496.
[27] Hogan MC,Bakeberg JL,Gainullin VG,et al.Identification of biomarkers for PKD1 using urinary exosomes[J].Journal of the American Society of Nephrology Jasn,2015,26(7):1661-1670.
[28] Huang X,Yuan T,Liang M,et al.Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer[J].European Urology,2015,67(1):33-41.
[29] Zhuo L,Ma YY,Wang J,et al.Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients[J].Oncotargets & Therapy,2016,9(Issue1):139-148.
[30] Isin M,Uysaler E,(¨overO)zgür E,et al.Exosomal lncRNA-p21 levelsmay help to distinguish prostate cancer from benign disease[J].Journal of UrologicalSurgery,2015,2(4):201.
[31] Bijnsdorp IV,Geldof AA,Lavaei M,et al.Exosomal ITGA3 interferes withnon-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients[J].Journal of Extracellular Vesicles,2013,2:1-10.
[32] Meng X,Müller V,Milde-Langosch K,et al.Diagnostic and prognostic relevance of circulating exosomal miR-373,miR-200a,miR-200b and miR-200c inpatients with epithelial ovarian cancer[J].Oncotarget,2016,7(13):16923-16935.
[33] El Andaloussi S,Lakhal S,M(¨overo)ger I,et al.Exosomes for targeted siRNA delivery across biological barriers[J].Advanced Drug Delivery Reviews,2013,65(3):391-397.
[34] Cooper JM,Wiklander PBO,Nordin JZ,et al.Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice[J].Movement Disorders:Official Journal of the Movement Disorder Society,2014,29(12):1476-1485.
[35] Aucher A,Rudnicka D,Davis DM.MicroRNAs tra-nsfer from human macrophages to hepato-carcinoma cells and inhibit proliferation[J].J Immunol,2013,191(12):6250-6260.
[36] Tian Y,Li S,Song J,et al.A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy[J].Biomaterials,2014,35(7):2383-2390.
[37] Yang T,Martin P,Fogarty B,et al.Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio[J].Pharmaceutical Research,2015,32(6):2003-2014.
[38] Marleau AM,Chen CS,Joyce JA,et al.Exosome removal as a therapeutic adjuvant in cancer[J].Journalof Translational Medicine,2012,10(1):134-142.
[39] Fabbri M,Paone A,Calore F,et al.MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response[J].Proc Natl Acad Sci USA,2012,109(31):E2110-E2116.
[40] 李秋文,肖文华,萨仁高娃,等.组蛋白去乙酰化酶抑制剂MS-275显著改变肝癌HepG2细胞中exosome免疫相关分子种类和含量[J].中华肝脏病杂志,2012,20(3):231-235. Li QW,Xiao WH,Saren GW,et al.Histone deacetylase inhibitor MS-275 treatment alters immune molecule content and categories in hepatocarcinoma exosomes[J].Chinese Journal of Hepatology,2012,20(3):231-235.
[41] Lü LH,Wan YL,Lin Y,et al.Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that eliciteffective natural killer cell antitumor responses in vitro[J].Journal of Biological Chemistry,2012,287(19):15874-15885.
[42] Romognoli GG,Zelante BB,Toniolo PA,et al.Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets[J].Frontiers in Immunology,2014,5:692.

相似文献/References:

[1]翁震,何杨.外泌体蛋白质组学分析在心血管疾病中应用的研究进展[J].现代检验医学杂志,2018,33(04):157.[doi:10.3969/j.issn.1671-7414.2018.04.044]
 WENG Zhen,HE Yang.Research Progress of Proteomic Analysis of Exosomes and Its Application in Cardiovascular Disease[J].Journal of Modern Laboratory Medicine,2018,33(04):157.[doi:10.3969/j.issn.1671-7414.2018.04.044]
[2]蒲双双.外泌体的提取、鉴定和保存方法研究进展[J].现代检验医学杂志,2018,33(05):157.[doi:10.3969/j.issn.1671-7414.2018.05.044]
 PU Shuang-shuang.Research Progress in Isolation,Identification and Preservation of Exosomes[J].Journal of Modern Laboratory Medicine,2018,33(04):157.[doi:10.3969/j.issn.1671-7414.2018.05.044]
[3]张翠平,陈婷婷,王成,等.儿童原发性肾病综合征患者尿液外泌体miR-23b-3p水平变化及其临床意义[J].现代检验医学杂志,2019,34(01):1.[doi:10.3969/j.issn.1671-7414.2019.01.001]
 ZHANG Cui-ping,CHEN Ting-ting,WANG Cheng,et al.Levels and Its Significance of Urinary Exosomal miR-23b-3p in Children with Nephrotic Syndrome[J].Journal of Modern Laboratory Medicine,2019,34(04):1.[doi:10.3969/j.issn.1671-7414.2019.01.001]
[4]张筱东,谢星星,李 佳,等.血清外泌体 miR-221 和 miR-378 水平检测在胃癌诊断中的应用研究[J].现代检验医学杂志,2020,35(06):52.[doi:doi:10.3969/j.issn.1671-7414.2020.06.013]
 ZHANG Xiao-dong,XIE Xing-xing,LI Jia,et al.Application Study of Serum Exosome miR-221 and miR-378 Detection in theDiagnosis of Gastric Cancer[J].Journal of Modern Laboratory Medicine,2020,35(04):52.[doi:doi:10.3969/j.issn.1671-7414.2020.06.013]
[5]夏艳艳,沈 瀚,许红攀,等.液体活检技术在肿瘤诊断中的最新研究进展[J].现代检验医学杂志,2021,36(03):157.[doi:10.3969/j.issn.1671-7414.2021.03.037]
 XIA Yan-yan,SHEN Han,XU Hong-pan,et al.Latest Research Progress of Liquid Biopsy in Tumor Diagnosis[J].Journal of Modern Laboratory Medicine,2021,36(04):157.[doi:10.3969/j.issn.1671-7414.2021.03.037]
[6]邰国梅,郭 京,王高仁.胸部放疗患者血浆外泌体中miR-7-5p与miR-17-5p的表达及临床意义[J].现代检验医学杂志,2021,36(04):35.[doi:10.3969/j.issn.1671-7414.2021.04.008]
 TAI Guo-mei,GUO Jing,WANG Gao-ren.Expression and Clinical Significance of miR-7-5p and miR-17-5p in PlasmaExosomes of Patients with Thoracic Radiotherapy[J].Journal of Modern Laboratory Medicine,2021,36(04):35.[doi:10.3969/j.issn.1671-7414.2021.04.008]
[7]刘先宁,汪 耀,潘士印,等.人角膜基质间充质干细胞外泌体的分离制备及鉴定[J].现代检验医学杂志,2021,36(05):114.[doi:10.3969/j.issn.1671-7414.2021.05.025]
 LIU Xian-ning,WANG Yao,PAN Shi-yin,et al.Isolation and Identification of Exosomes Derived from Human CornealStromal Mesenchymal Stem Cells[J].Journal of Modern Laboratory Medicine,2021,36(04):114.[doi:10.3969/j.issn.1671-7414.2021.05.025]
[8]黄德发,张文娟,陈 杰,等.三种方法提取血清外泌体的比较研究[J].现代检验医学杂志,2021,36(06):139.[doi:10.3969/j.issn.1671-7414.2021.06.030]
 HUANG De-fa,ZHANG Wen-juan,CHEN Jie,et al.Comparative Study on Three Methods for Extraction of Serum Exosomes[J].Journal of Modern Laboratory Medicine,2021,36(04):139.[doi:10.3969/j.issn.1671-7414.2021.06.030]
[9]王 路,叶 莎,韩 霞,等.循环外泌体miRNA 检测对肝细胞癌临床诊断效能的Meta 分析[J].现代检验医学杂志,2022,37(04):59.[doi:10.3969/j.issn.1671-7414.2021.04.012]
 WANG Lu,YE Sha,HAN Xia,et al.Meta-Analysis of the Diagnostic Value of Circulating Exosomes miRNA Detection for Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2022,37(04):59.[doi:10.3969/j.issn.1671-7414.2021.04.012]
[10]赵 波,刘永利,李京京.血浆外泌体miR-4306 表达水平联合CT 征象对单发非实性肺结节良恶性鉴别的价值研究[J].现代检验医学杂志,2023,38(04):46.[doi:10.3969/j.issn.1671-7414.2023.04.008]
 ZHAO Bo,LIU Yongli,LI Jingjing.Value of Plasma Exosomal miR-4306 Expression Levels Combined with CT Signs for the Identification of Benign and Malignant Solitary Non-Solid Pulmonary Nodules[J].Journal of Modern Laboratory Medicine,2023,38(04):46.[doi:10.3969/j.issn.1671-7414.2023.04.008]

备注/Memo

备注/Memo:
作者简介:蒲双双(1983-),女,硕士,研究方向:分子生物学,E-mail:236208893@qq.com。 通讯作者:李金星(1964-),男,硕士,主任医师,检验科主任,E-mail:ljxjyk@163.com。
更新日期/Last Update: 2018-08-16